Axsome Therapeutics (AXSM) Priced

Developing novel therapies for pain and CNS disorders utilizing the 505(b)(2) pathway.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $4.35 +0.18 (+4.2%)
First Day Return -2.9%
Return from IPO -53.6%
 
Axsome Therapeutics IPO News more
  • .
IPO Data
IPO File Date 10/13/2015
Offer Price $9.00
Price Range $11.00 - $13.00
Offer Shares (mm) 5.7
Deal Size ($mm) 51
 
IPO Data
IPO Date 11/19/2015
Offer Price $9.00
Price Range $11.00 - $13.00
Offer Shares (mm) 5.7
Deal Size ($mm) $51
 
Underwriters
more
Business Overview
Developing novel therapies for pain and CNS disorders utilizing the 505(b)(2) pathway.
Developing novel therapies for pain and CNS disorders utilizing the 505(b)(2) pathway.
more
Company Data
Headquarters New York, NY
Founded 2012
Employees 9
Website www.axsome.com
 

Performance vs. IPO Index (IPOUSA)